Brain Imaging Made Easier with NeuroTrALE, an Open-Source Tool for Data Processing
In late 2023, the first drug with potential to slow the progression of Alzheimer's disease was approved by the U.S. Federal Drug Administration. Alzheimer's is one of many debilitating neurological disorders that together affect one-eighth…